Member Info for Badsterman

Furthermore, the tests showed Robotaxis "dropping off passengers in the middle of multilane roads"

This could have been quickly and safely resolved with a Guident intervention.

A Guardian headline today states "Tesla shareholders sue Elon Musk for allegedly hyping up faltering Robotaxi"

There is a solution Elon.....

OB is back!! 👏

I thought you'd retired to your Greek island retreat with Kleftiko and Metaxa.

Are ya still grafting OB?

A minor infraction.

Independent Directors could be making sure the books are squeaky clean before signing a big contract?

Judith Batchelar is ex Sainsbury's, she knows the protocols.

Lemon....."It's a game changer"

No it isn't, there no cash in the deal. Have you seen the SP reaction?

Do you know how many companies are developing products in the "personalised medicine" space? I'll tell you, thousands of them (big and small) all using AI tools.

Until Mark can come up with a deal that involves money upfront, thus preventing another raise, it'll remain the same old Valirx.

Take your rose tinted specs off, just for a minute.

You missed the important bit - "initial revenues under the Agreement are expected to be modest".

That's all the market cares about.

Wakey,.wakey....🤔

Now have the same registered address as KZG, must be the Wardle connection.

A good read,

Using PDC cell lines and AI to optimise drug selection, although the article points out the datasets were incomplete and further studies are required.

Can Mark, or another investor/partner, see a road to commercialisation for this modelling technology?

It's yet another opportunity that Mark's exploring, he's certainly working extremely hard to turn Valirx around.

🤞

Unless, of course, Cliff found some cash to exercise TEK's warrants in LUCY.

Didn't he sell a small chunk of SALT the other day? I'm losing track.🙄

LUCY raise a further $4.8 million via warrants = yet more dilution.

https://finance.yahoo.com/news/innovative-eyewear-inc-announces-4-110000139.html

Personally, I think they need to install a camera/heads up display just to keep pace with competitors.

It's turned into a money pit.

Not correct Sir Mark

LUCY have 3,094,575 share in issue, of which TEK own 259,455 (see latest RNS) thus an 8.38% holding = $916,000 ish.

Therein lies the problem with TEK, (which has been discussed multiple times on this board).

The constant dilution, across all the portfolio companies, explains the large discount to NAV.

"The initial £6 million milestones are payable in cash or the equivalent value in new ordinary shares in Ambrose with the issue price determined by the latest issue of shares in Ambrose, at the discretion of Ambrose. Payment of milestones in cash is subject to Ambrose raising capital in due course."

So Ambrose still haven't raised any funds and reserve the right to issue shares instead. Wilson-Waterworth has a chequered history running pharma startups (see companies house).

Whilst it's good news it ain't a game changer, CLX001 is still the big one.

Pedro, I've been here several years and Cliff's companies all follow the same pattern, without exception (note the GENAI promises in the latest raise).

Promises, poor results, raise.

Promises, poor results, raise...ad finitum.

His son does the same at LUCY, Rauker does the same at BELL and Guiney is doing the same at SALT. Too early to judge Cruz at GENIP but revenue doesn't cover costs there either.

I'm waiting for the Guident IPO, that's all we have left.

More from ME (LinkedIn account required);

https://tinyurl.com/ycss8jtm

He's doing his level best to gain commercial traction.

Although I expect the usual suspects, Grainger et al, will be along shortly with their sarcastic retorts.

Beautiful RNS...

Cash and a new project with Unilever, who state "We will continue to engage with the world class team at Aptamer Group to explore this and ADDITIONAL opportunities."

👍

Sareum haven't actually missed THIS deadline, yet.

By all means direct your critique at the Board, but at least allow them the correct time period in the RNS.

Apologist? For pointing out the toxicology study timeline, as communicated by the Board?

Let's not let the facts get in the way of a good whinge, eh?

The Board provided a detailed update less than a month ago.

The start date for toxicology studies was by the of May 2025. There are still three full business days to go (and the rest of today).

So, why don't you read the latest RNS instead of whining about lack of communication.....blah blah blah....

🙄

Ambrose's six month extension expires tomorrow...

Place ya bets. 🤣